Does jugular AVF stent effect bp
jugular arteriovenous fistula stent blood pressure
jugular AVF stent effect blood pressure hemodynamics
arteriovenous fistula closure stent blood pressure hypertension
ROX coupler central arteriovenous fistula hypertension blood pressure
| AVF State | SVR | Cardiac Output | BP Effect |
|---|---|---|---|
| AVF open (active shunt) | Decreased | Increased | BP falls (especially diastolic) |
| AVF occluded by stent | Increased | Normalized | BP rises |
| Outflow stenosis treated | Restored shunt | Maintained ↑ CO | BP remains lower |
Does jugular AVF alters bp
arteriovenous fistula blood pressure hemodynamic effects
jugular arteriovenous fistula blood pressure hemodynamic effect mechanism
| Parameter | Effect of AVF Creation | Effect of AVF Ligation/Closure |
|---|---|---|
| Systolic BP | ↓ 8.7 mmHg | ↑ 5.2 mmHg |
| Diastolic BP | ↓ 5.9 mmHg | ↑ 3.8 mmHg |
| Mean arterial pressure | ↓ 6.6 mmHg | ↑ 3.7 mmHg |
Paradoxical hypertension reflex subsides itself or medication is needed
paradoxical hypertension arteriovenous fistula closure ligation
paradoxical hypertension after AVF closure ligation treatment self-limiting medication needed
hypertension after arteriovenous fistula ligation treatment management
paradoxical hypertension after carotid endarterectomy carotid sinus baroreceptor mechanism treatment
| Type | Natural Course | Timeframe |
|---|---|---|
| Unilateral carotid sinus disruption | Usually self-limiting | Days to weeks; rarely persists beyond 4-6 weeks |
| Bilateral carotid sinus disruption | More prolonged instability | Can last up to 12 weeks |
| SVR rebound post-closure | Usually resolves as vascular adaptation occurs | Days to 2-3 weeks |
| Drug Class | Agent | Role |
|---|---|---|
| IV beta-blocker | Labetalol, Esmolol | First-line acute control; counters sympathetic surge |
| IV calcium channel blocker | Nicardipine, Clevidipine | Smooth, titratable reduction |
| IV vasodilator | Nitroprusside, Nitroglycerin | Rapid-onset for hypertensive emergencies |
| Oral (maintenance) | Amlodipine, Clonidine | Bridge while baroreceptors recalibrate |
| Scenario | Expected Course | Medication Needed? |
|---|---|---|
| Mild BP elevation (SBP 140-160) | Self-limiting, days to weeks | Monitor; oral antihypertensive optional |
| Moderate (SBP 160-180) | Self-limiting but risky | Yes - oral agents, close monitoring |
| Severe/labile (SBP >180 or symptomatic) | Dangerous without treatment | Yes - IV agents, ICU-level monitoring |
| Bilateral baroreceptor disruption | Prolonged instability up to 12 weeks | Yes - sustained pharmacotherapy needed |